Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) Operating Expenses: 2009-2025

Historic Operating Expenses for Innoviva (INVA) over the last 17 years, with Sep 2025 value amounting to $41.0 million.

  • Innoviva's Operating Expenses rose 37.59% to $41.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.0 million, marking a year-over-year increase of 81.09%. This contributed to the annual value of $321.3 million for FY2024, which is 176.13% up from last year.
  • According to the latest figures from Q3 2025, Innoviva's Operating Expenses is $41.0 million, which was up 19.09% from $34.4 million recorded in Q2 2025.
  • In the past 5 years, Innoviva's Operating Expenses registered a high of $87.7 million during Q2 2022, and its lowest value of -$219.2 million during Q3 2022.
  • For the 3-year period, Innoviva's Operating Expenses averaged around $32.6 million, with its median value being $34.3 million (2024).
  • The largest annual percentage gain for Innoviva's Operating Expenses in the last 5 years was 1,956.38% (2022), contrasted with its biggest fall of 765.76% (2022).
  • Innoviva's Operating Expenses (Quarterly) stood at -$25.3 million in 2021, then plummeted by 765.76% to -$219.2 million in 2022, then soared by 91.47% to -$18.7 million in 2023, then skyrocketed by 259.26% to $29.8 million in 2024, then soared by 37.59% to $41.0 million in 2025.
  • Its Operating Expenses stands at $41.0 million for Q3 2025, versus $34.4 million for Q2 2025 and $31.9 million for Q1 2025.